Next Generation iBOT
Wheelchair, Stair Climbing. 510(k) K172601, from Deka Research & Development Corp. (Manchester, NH). Product code IMK, class 2.
As of Nov 16, 2026, K172601 is an FDA 510(k) held by Deka Research & Development Corp., substantially equivalent on Mar 2, 2018 after 184 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Mar 2, 2018
- Review time: 184 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Next Generation iBOT is intended to provide indoor and outdoor mobility to persons restricted to a sitting position who meet the requirements of the user assessment and training certification program. The device is intended to climb stairs. Companions who are required to provide assistance during Assisted Stair Climbing Mode must meet the requirements of the training certification program.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Independence (Tm) Ibot 3000/4000 Mobility SystemP020033 · Independence Technology, LLC · Aug 13, 2003
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- iBOT Personal Mobility Device (iBOT PMD)K210920 · Mobius Mobility · Jun 16, 2021
Other IMK Clearances
The newest 510(k)s for the same product code; see every IMK device- iBOT® PMDK243442 · Mobius Mobility · Jan 30, 2025
- iBOT Personal Mobility Device (iBOT PMD)K210920 · Mobius Mobility · Jun 16, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 30, 2017
- Review panel
- Physical Medicine
- Regulation
- 21 CFR 890.3890
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files